Alibaba Health Information Technology Ltd
00241: XHKG (HKG)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| !n | LOCK|v>kGf | LOCK|&LrT$^c |
Alibaba Health Earnings: Revenue Normalizes As Platform Strength Holds, Growth Concerns Remain
Alibaba Health's first-half fiscal 2026 (year ending March) revenue increased 17% year on year, driven by strength in its direct sales platform due to robust sales of prescription drugs and medical devices.
